Skandinaviska Enskilda Banken (SEB)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
88,698
+11,100
| +14% | +$610K | 0.02% | 428 |
|
|
2025
Q1 | $5.48M | Hold |
77,598
| – | – | 0.03% | 398 |
|
|
2024
Q4 | $5.08M | Buy |
77,598
+17,729
| +30% | +$1.16M | 0.02% | 409 |
|
|
2024
Q3 | $4.21M | Sell |
59,869
-5,906
| -9% | -$415K | 0.02% | 440 |
|
|
2024
Q2 | $5.42M | Hold |
65,775
| – | – | 0.03% | 362 |
|
|
2024
Q1 | $5.75M | Buy |
65,775
+2,211
| +3% | +$193K | 0.03% | 375 |
|
|
2023
Q4 | $6.13M | Sell |
63,564
-50,305
| -44% | -$4.85M | 0.04% | 347 |
|
|
2023
Q3 | $10.1M | Sell |
113,869
-85,947
| -43% | -$7.6M | 0.07% | 250 |
|
|
2023
Q2 | $17.3M | Buy |
199,816
+98
| +0% | +$8.5K | 0.11% | 187 |
|
|
2023
Q1 | $19.4M | Buy |
199,718
+7,333
| +4% | +$713K | 0.14% | 161 |
|
|
2022
Q4 | $19.9M | Buy |
192,385
+117,079
| +155% | +$12.1M | 0.15% | 155 |
|
|
2022
Q3 | $6.38M | Sell |
75,306
-4,644
| -6% | -$394K | 0.05% | 312 |
|
|
2022
Q2 | $6.63M | Sell |
79,950
-2,697
| -3% | -$223K | 0.05% | 312 |
|
|
2022
Q1 | $6.37M | Sell |
82,647
-4,214
| -5% | -$325K | 0.04% | 354 |
|
|
2021
Q4 | $7.74M | Buy |
86,861
+8,570
| +11% | +$763K | 0.04% | 343 |
|
|
2021
Q3 | $6.05M | Buy |
78,291
+922
| +1% | +$71.3K | 0.03% | 378 |
|
|
2021
Q2 | $6.46M | Sell |
77,369
-12,100
| -14% | -$1.01M | 0.04% | 365 |
|
|
2021
Q1 | $6.76M | Sell |
89,469
-12,732
| -12% | -$961K | 0.04% | 343 |
|
|
2020
Q4 | $8.96M | Buy |
102,201
+4,217
| +4% | +$370K | 0.06% | 259 |
|
|
2020
Q3 | $7.46M | Buy |
97,984
+35,487
| +57% | +$2.7M | 0.05% | 267 |
|
|
2020
Q2 | $7.71M | Sell |
62,497
-15,362
| -20% | -$1.89M | 0.06% | 258 |
|
|
2020
Q1 | $6.58M | Sell |
77,859
-37,491
| -33% | -$3.17M | 0.07% | 241 |
|
|
2019
Q4 | $9.75M | Buy |
115,350
+8,774
| +8% | +$742K | 0.08% | 224 |
|
|
2019
Q3 | $7.18M | Sell |
106,576
-1,000
| -0.9% | -$67.4K | 0.06% | 258 |
|
|
2019
Q2 | $9.21M | Sell |
107,576
-15,544
| -13% | -$1.33M | 0.08% | 221 |
|
|
2019
Q1 | $10.9M | Buy |
123,120
+56,788
| +86% | +$5.04M | 0.1% | 174 |
|
|
2018
Q4 | $5.65M | Sell |
66,332
-14,328
| -18% | -$1.22M | 0.05% | 257 |
|
|
2018
Q3 | $7.82M | Sell |
80,660
-19,900
| -20% | -$1.93M | 0.06% | 229 |
|
|
2018
Q2 | $9.47M | Buy |
100,560
+7,314
| +8% | +$689K | 0.08% | 184 |
|
|
2018
Q1 | $7.56M | Buy |
93,246
+46,486
| +99% | +$3.77M | 0.07% | 171 |
|
|
2017
Q4 | $4.17M | Buy |
46,760
+626
| +1% | +$55.8K | 0.04% | 309 |
|
|
2017
Q3 | $4.29M | Sell |
46,134
-2,800
| -6% | -$261K | 0.04% | 319 |
|
|
2017
Q2 | $4.44M | Sell |
48,934
-7,900
| -14% | -$717K | 0.04% | 317 |
|
|
2017
Q1 | $4.99M | Sell |
56,834
-4,900
| -8% | -$430K | 0.05% | 279 |
|
|
2016
Q4 | $5.11M | Sell |
61,734
-6,656
| -10% | -$551K | 0.06% | 230 |
|
|
2016
Q3 | $6.33M | Sell |
68,390
-4,300
| -6% | -$398K | 0.07% | 210 |
|
|
2016
Q2 | $5.66M | Sell |
72,690
-2,000
| -3% | -$156K | 0.06% | 220 |
|
|
2016
Q1 | $6.16M | Sell |
74,690
-400
| -0.5% | -$33K | 0.07% | 210 |
|
|
2015
Q4 | $7.87M | Buy |
+75,090
| New | +$7.87M | 0.1% | 151 |
|